搜索临床试验以:BILR 355 BS - 高剂量悬浮液
总计49个结果
-
Boehringer Ingelheim终止
-
Boehringer Ingelheim完全的
-
Boehringer Ingelheim完全的
-
Ohio State University Comprehensive Cancer CenterVarian Medical Systems主动,不招人
-
AllerganMAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan完全的
-
AllerganMAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan; Q-Pharm Pty Limited完全的
-
Crucell Holland BVThe PATH Malaria Vaccine Initiative (MVI); Seattle Children's Research Institute (SCRI)完全的
-
Instituto de Ciencia y Tecnología de Alimentos...Ministerio de Economía y Competitividad, Spain完全的
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AIDS Clinical Trials Group; SAb Biotherapeutics... 和其他合作者完全的
-
M.D. Anderson Cancer Center招聘中Ann Arbor I 期原发性纵隔(胸腺)大 B 细胞淋巴瘤 | Ann Arbor II 期原发性纵隔(胸腺)大 B 细胞淋巴瘤 | Ann Arbor III 期原发性纵隔(胸腺)大 B 细胞淋巴瘤 | Ann Arbor IV 期原发性纵隔(胸腺)大 B 细胞淋巴瘤美国
-
OHSU Knight Cancer InstituteAbbVie; Oregon Health and Science University招聘中B 急性淋巴细胞白血病 | 复发性 B 型急性淋巴细胞白血病 | 复发性混合表型急性白血病 | B 伴有 t(9;22)(q34.1;q11.2) 的急性淋巴细胞白血病; BCR-ABL1 | 混合表型急性白血病美国